Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
123.50    1.50 (1.24%)
Bid:
121.00
Ask:
123.50
Spread: 2.50 (2.066%)
Market Cap: £196.76m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Share Buyback Programme

17 Sep 2019 07:00

RNS Number : 5232M
Redcentric PLC
17 September 2019
 

17 September 2019

Redcentric plc

("Redcentric" or the "Company")

 

 Share Buyback Programme

 

Redcentric plc (AIM: RCN) announces that it has approved a share buyback programme of ordinary shares of 0.1p in the capital of the Company ("Ordinary Shares") for an aggregate purchase price of up to £2 million (the "Buyback Programme"). The Buyback Programme forms part of the Group's broader strategy to deliver shareholder value.

 

The Buyback Programme will be independently managed by finnCap Ltd, the Company's joint broker, which will make trading decisions independently and without the influence of the Company.

 

The Buyback Programme is in accordance with the terms of the Company's authority to make market purchases of its own Ordinary Shares which was granted at the Company' Annual General Meeting on 2 September 2019 (the "Authority"). The maximum price paid per Ordinary Share is to be no more than 105 per cent. of the average middle market closing price of an Ordinary Share for the five business days preceding the date of purchase. The Buyback Programme will commence today and will continue until such time that the board of directors of the Company decides to end the Buyback Programme, at which point a further announcement will be made by the Company.

 

Any Ordinary Shares acquired as a result of the Buyback Programme will be held in treasury and be announced to the market without delay.

 

Due to the limited liquidity in the issued Ordinary Shares, any Buyback of Ordinary Shares pursuant to the Authority on any trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares on AIM and may exceed 25 per cent. of the average daily trading volume, being the limit laid down in Article 5(1) of Regulation (EU) No 596/2014 and, accordingly, the Company will not benefit from the exemption contained in this Article.

 

The Company confirms that it currently has no other unpublished price sensitive information other than what has been disclosed above.

 

 Enquiries:

 

Redcentric plc

 

Peter Brotherton, Chief Executive Officer

Via Tulchan

Dean Barber, Chief Financial Officer

 

 

 

Tulchan

+44 (0)20 7353 4200

James Macey White / Matt Low

 

 

 

Numis Securities Limited - Nomad and Joint Broker

+44 (0)20 7260 1000

Simon Willis / Oliver Hardy

 

 

 

finnCap Ltd - Joint Broker

+44 (0)20 7220 0500

Stuart Andrews / Rhys Williams

 

 

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSFMGMLLVVGLZM
Date   Source Headline
7th Jul 20217:00 amRNSHolding(s) in Company
15th Jun 20217:00 amRNSDelay of Full Year Results
28th May 20217:00 amRNSExercise of options
28th Apr 20217:00 amRNSDirectorate Change
13th Apr 20215:27 pmRNSHolding(s) in Company
12th Apr 20212:47 pmRNSHolding(s) in Company
6th Apr 20217:00 amRNSTrading Statement
1st Apr 20217:00 amRNSExercise of Options
9th Mar 20215:00 pmRNSDirector/PDMR Shareholding
8th Mar 202112:52 pmRNSHolding(s) in Company
22nd Feb 20213:15 pmRNSHolding(s) in Company
19th Feb 20213:21 pmRNSHolding(s) in Company
19th Feb 202112:43 pmRNSHolding(s) in Company
8th Jan 20217:00 amRNSExercise of Options
6th Jan 20214:52 pmRNSHolding(s) in Company
6th Jan 20214:52 pmRNSHolding(s) in Company
6th Jan 20214:38 pmRNSHolding(s) in Company
23rd Dec 20207:00 amRNSDirector/PDMR Shareholding
22nd Dec 20205:13 pmRNSHolding(s) in Company
22nd Dec 20203:28 pmRNSHolding(s) in Company
21st Dec 20205:18 pmRNSHolding(s) in Company
9th Dec 20207:01 amRNSIssue of Options
9th Dec 20207:00 amRNSExercise of Options
8th Dec 20207:00 amRNSCompletion of Restitution Scheme
30th Nov 20207:00 amRNSRestitution Scheme Update
24th Nov 20207:00 amRNSRestitution Scheme Update
23rd Nov 20207:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
12th Nov 20207:01 amRNSHalf Year Results
12th Nov 20207:00 amRNSEnd of formal sale process
11th Nov 20205:48 pmRNSStatement regarding Redcentric plc
9th Nov 20205:32 pmRNSForm 8.3 - Redcentric Plc
2nd Nov 20204:00 pmRNSRule 2.9 Announcement
2nd Nov 20204:00 pmRNSRestitution Scheme Update
30th Oct 20202:45 pmRNSForm 8.3 - Redcentric PLC
27th Oct 20202:11 pmRNSForm 8.3 - Redcentric PLC
20th Oct 202012:09 pmRNSForm 8.3 - Redcentric Plc
19th Oct 20207:02 amRNSRule 2.9 Announcement
19th Oct 20207:01 amRNSRestitution Scheme Update
19th Oct 20207:00 amRNSExercise of Options
15th Oct 20207:00 amRNSTrading Update
13th Oct 202012:28 pmRNSForm 8.5 (EPT/RI) - Redcentric Plc
13th Oct 202010:31 amRNSForm 8.3 - Redcentric PLC
12th Oct 20203:00 pmRNSForm 8.3 - Redcentric PLC
12th Oct 20207:00 amRNSRule 2.9 Announcement
12th Oct 20207:00 amRNSRestitution Scheme Update
9th Oct 20203:15 pmRNSForm 8.3 - Redcentric PLC
9th Oct 20207:00 amRNSRule 2.9 Announcement
9th Oct 20207:00 amRNSExercise of Options
5th Oct 20207:00 amRNSRule 2.9 Announcement
5th Oct 20207:00 amRNSRestitution Scheme Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.